- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02364908
Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus (ESSTIM)
Prospective Evaluation of Adherence to Antimalarials in Patients With Systemic Lupus and Role of Therapeutic Education
This study is a biomedical, open label, therapeutic strategy, interventional, non-randomized, multicenter study to evaluate the non compliance to antimalarials in patients with systemic lupus in the Nord Pas-de-Calais region (FRANCE). It is conducted in two visits. These visits consist in obtaining blood sample, performing a clinical examination and filling in a questionnaire (Quality Of Life, Coping...).
The goal for the noncompliants patients is to guide them towards the therapeutic education with professionals (nurses and physicians).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Boulogne sur Mer, France, 62321
- CH Hôpital Duchenne
-
Douai, France, 59507
- CH DOUAI
-
Dunkerque, France, 59385
- Ch Dunkerque
-
Lens, France, 62307
- CH du Dr Schaffner
-
Lille, France
- CHRU, Hôpital Huriez
-
Roubaix, France, 59056
- Victor Provo Hospital
-
Valenciennes, France, 59322
- Valenciennes Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients with a systemic lupus with ACR criteria (at least 4 criterias)
- patients with antimalarials for at least 3 months with a minimum dose of 200 mg/day.
Exclusion Criteria:
- patients who refuse to sign the informed consent
- patients who are under guardianship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Patients with Systemic Lupus
|
This is the group sessions aimed to convey additional information to patients about their disease.
The main objective is to learn how to better anticipate any medical problems and better manage daily life with the disease.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
measure of the frequency of patients with systemic lupus noncompliants to their antimalarials treatment.
Time Frame: baseline, at 12 months
|
baseline, at 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
hydroxychloroquinémie
Time Frame: between 6 months at 12 months
|
Monitoring of blood levels of hydroxychloroquinémie
|
between 6 months at 12 months
|
number of non- adherent patients
Time Frame: at 12 months
|
Identification of the number of non- adherent patients are being enrolled in Education Protocol Patient and number of sessions followed ;
|
at 12 months
|
quality of life scale Coping
Time Frame: baseline, at 12 months
|
scale Coping ( WCC-R Par COUSSON et al. (1996) ) scale MASRI, scale MMAS-8-item
|
baseline, at 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Eric Hachulla, MD, PhD, University Hospital, Lille
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013_65
- 2014-A00735-42 (Other Identifier: ID-RCB number, ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systemic Lupus Erythematosus
-
SanofiCompletedCutaneous Lupus Erythematosus-Systemic Lupus ErythematosusJapan
-
Kyowa Kirin Co., Ltd.RecruitingHealthy Volunteers | Systemic Lupus Erythematosus (SLE) | Cutaneous Lupus Erythematosus (CLE)Japan
-
Second Xiangya Hospital of Central South UniversityNational Natural Science Foundation of China; Hunan Provincial Natural Science... and other collaboratorsActive, not recruitingCutaneous Lupus Erythematosus | Systemic Lupus Erythematosus RashChina
-
Novartis PharmaceuticalsNot yet recruitingSystemic Lupus Erythematosus, SLE
-
Changhai HospitalRui Therapeutics Co., LtdRecruitingSystemic Lupus Erythematosus (SLE)China
-
Bioray LaboratoriesFirst Affiliated Hospital of Zhejiang UniversityRecruitingSystemic Lupus Erythematosus (SLE)China
-
Sohag UniversityNot yet recruitingSystemic Lupus Erythematosus (SLE)
-
BiogenEnrolling by invitationSystemic Lupus Erythematosus (SLE)Spain, Bulgaria, United States, China, Serbia, Mexico, Korea, Republic of, Chile, Argentina, Poland, Japan, Romania, Colombia, Hungary, Czechia, United Kingdom, Taiwan, Brazil, Israel, France
-
AbbVieCompletedSystemic Lupus Erythematosus (SLE)United States, Argentina, Australia, Bulgaria, China, Colombia, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Puerto Rico, Spain, Taiwan, United Kingdom
-
AmgenTerminatedActive Systemic Lupus ErythematosusKorea, Republic of, United States, Taiwan, Canada, Spain, Italy, Mexico, Japan, Turkey, Austria, Greece, Colombia, Switzerland, Poland, France, Bulgaria, Hong Kong, Russian Federation, Chile
Clinical Trials on therapeutic education
-
Roy La Touche ArbizuUniversidad Autonoma de Madrid; Centro Universitario La Salle; Servicio Madrileño...UnknownLow Back Pain | Chronic Nonspecific Low Back PainSpain
-
Nantes University HospitalTerminated
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Assistance Publique - Hôpitaux de ParisCentre Leon Berard; Ministry of Health, France; Université Montpellier; Telecom... and other collaboratorsUnknownKidney Transplantation | End-stage Renal Disease | Dialysis
-
Beauvais HospitalNot yet recruitingNutrition Aspect of Cancer
-
ResicardAssistance Publique - Hôpitaux de Paris; Novartis; Agence Regionale de Sante... and other collaboratorsActive, not recruitingHeart FailureFrance
-
University Hospital, Strasbourg, FranceNot yet recruitingAuto-immune Myasthenia
-
University Hospital, Clermont-FerrandFrench Society of RheumatologyCompletedRheumatoid Arthritis | SpondyloarthritisFrance
-
University Hospital, ToulouseCompleted
-
Hôpital Léon BérardWithdrawn